Published in Am J Trop Med Hyg on March 01, 2010
Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One (2014) 1.57
Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection. Eukaryot Cell (2011) 1.40
Toxoplasmosis: a global threat. J Glob Infect Dis (2011) 1.19
Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades. Am J Trop Med Hyg (2014) 1.13
Toxoplasmosis. Handb Clin Neurol (2013) 1.11
Avirulent uracil auxotrophs based on disruption of orotidine-5'-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondii. Infect Immun (2010) 1.08
Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201. Vaccine (2010) 1.04
Toxoplasma gondii merozoite gene expression analysis with comparison to the life cycle discloses a unique expression state during enteric development. BMC Genomics (2014) 0.99
Neglected parasitic infections in the United States: toxoplasmosis. Am J Trop Med Hyg (2014) 0.96
Congenital Toxoplasmosis. J Pediatric Infect Dis Soc (2014) 0.92
Repurposing the open access malaria box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolytica. Antimicrob Agents Chemother (2014) 0.90
Toxoplasma gondii infection: relationship between seroprevalence and risk factors among primary schoolchildren in the capital areas of Democratic Republic of São Tomé and Príncipe, West Africa. Parasit Vectors (2012) 0.84
Toxoplasmosis: new challenges for an old disease. Eye (Lond) (2012) 0.83
Nonreplicating, cyst-defective type II Toxoplasma gondii vaccine strains stimulate protective immunity against acute and chronic infection. Infect Immun (2015) 0.82
Ocular Toxoplasmosis: Controversies in Primary and Secondary Prevention. J Neuroinfect Dis (2013) 0.80
Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study. Sci Rep (2016) 0.80
Seroprevalence of Toxoplasma gondii in White-Tailed Deer (Odocoileus virginianus) and Free-Roaming Cats (Felis catus) Across a Suburban to Urban Gradient in Northeastern Ohio. Ecohealth (2014) 0.79
Ocular toxoplasmosis in Iran: 40 cases analysis. Int J Ophthalmol (2011) 0.79
Understanding Toxoplasmosis in the United States Through "Large Data" Analyses. Clin Infect Dis (2016) 0.78
Functional Analyses of the Toxoplasma gondii DNA Gyrase Holoenzyme: A Janus Topoisomerase with Supercoiling and Decatenation Abilities. Sci Rep (2015) 0.78
Neglected parasitic infections and poverty in the United States. PLoS Negl Trop Dis (2014) 0.77
The Impact of Short-Term, Intensive Antifolate Treatment (with Pyrimethamine and Sulfadoxine) and Antibiotics Followed by Long-Term, Secondary Antifolate Prophylaxis on the Rate of Toxoplasmic Retinochoroiditis Recurrence. PLoS Negl Trop Dis (2016) 0.75
Drugs in development for toxoplasmosis: advances, challenges, and current status. Drug Des Devel Ther (2017) 0.75
Clinical Features and Risk Factors of Patients with Presumed Ocular Toxoplasmosis. J Ophthalmic Vis Res (2016) 0.75
Pyrimidine Pathway-Dependent and -Independent Functions of the Toxoplasma gondii Mitochondrial Dihydroorotate Dehydrogenase. Infect Immun (2016) 0.75
Seroepidemiology of toxoplasmosis in rural and urban communities from Los Rios Region, Chile. Infect Ecol Epidemiol (2016) 0.75
Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review. Drugs R D (2017) 0.75
Toxoplasma gondii in the Food Supply. Pathogens (2017) 0.75
A prospective randomized trial of azithromycin versus trimethoprim/sulfamethoxazole in treatment of toxoplasmic retinochoroiditis. J Curr Ophthalmol (2016) 0.75
PCR-based Diagnosis of Toxoplasma Parasite in Ocular Infections Having Clinical Indications of Toxoplasmosis. Iran J Parasitol (2017) 0.75
Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. Lancet (1997) 4.36
Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol (2001) 4.12
Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol (2009) 3.27
Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade. Am J Trop Med Hyg (2007) 3.09
Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis (2001) 2.86
Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol (2003) 2.42
An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol (1992) 2.41
Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg Infect Dis (2006) 2.00
An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol (2002) 1.68
Preventing congenital toxoplasmosis. MMWR Recomm Rep (2000) 1.43
Genetic analysis of the diversity in Toxoplasma gondii. Ann Ist Super Sanita (2004) 1.09
Treating ocular toxoplasmosis: current evidence. Mem Inst Oswaldo Cruz (2009) 0.95
Ophthalmic survey of a community. 1. Abnormalities of the ocular fundus. Am J Ophthalmol (1972) 0.88
Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol (2010) 2.50
Birdshot chorioretinopathy. Surv Ophthalmol (2005) 1.87
Recently acquired Toxoplasma gondii infection, Brazil. Emerg Infect Dis (2006) 1.79
Graft failure after penetrating keratoplasty in eyes with Ahmed valves. Am J Ophthalmol (2010) 1.66
Laser flare-cell photometry: methodology and clinical applications. Surv Ophthalmol (2004) 1.50
The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol (2002) 1.48
Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference. Am J Ophthalmol (2006) 1.29
Contrast sensitivity and color vision in HIV-infected individuals without infectious retinopathy. Am J Ophthalmol (2006) 1.21
Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology (2006) 1.20
Vision function in HIV-infected individuals without retinitis: report of the Studies of Ocular Complications of AIDS Research Group. Am J Ophthalmol (2008) 1.15
Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol (2006) 1.14
Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review. Clin Infect Dis (2013) 1.11
Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol (2008) 1.11
Strong associations between specific HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Vis Sci (2003) 1.08
Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Invest Ophthalmol Vis Sci (2012) 1.07
Identification of an atypical strain of toxoplasma gondii as the cause of a waterborne outbreak of toxoplasmosis in Santa Isabel do Ivai, Brazil. J Infect Dis (2010) 1.07
Accuracy and reliability of telemedicine for diagnosis of cytomegalovirus retinitis. Am J Ophthalmol (2011) 1.06
Bilateral uveitis associated with fluoroquinolone therapy. Cutan Ocul Toxicol (2011) 1.05
Laser flare photometry and complications of chronic uveitis in children. Am J Ophthalmol (2003) 1.02
Anterior segment and external ocular disorders associated with human immunodeficiency virus disease. Surv Ophthalmol (2007) 1.01
Hemorheologic abnormalities associated with HIV infection: altered erythrocyte aggregation and deformability. Invest Ophthalmol Vis Sci (2006) 0.97
Longitudinal cohort study of patients with birdshot chorioretinopathy. III. Macular imaging at baseline. Am J Ophthalmol (2007) 0.96
Association between retinal nerve fiber layer thickness and abnormalities of vision in people with human immunodeficiency virus infection. Am J Ophthalmol (2012) 0.95
Central serous chorioretinopathy after solid organ transplantation. Ophthalmology (2006) 0.94
Standardized visual field assessment for patients with birdshot chorioretinopathy. Ocul Immunol Inflamm (2006) 0.93
Topical tacrolimus treatment of atopic eyelid disease. Am J Ophthalmol (2003) 0.93
HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California. Hum Immunol (2004) 0.91
Clinician versus reading center assessment of cytomegalovirus retinitis lesion size. Ophthalmology (2005) 0.90
Survey of ophthalmologists about ocular toxoplasmosis. Am J Ophthalmol (2005) 0.90
Microbiologic and histopathologic assessment of corneal biopsies in the evaluation of microbial keratitis. Am J Ophthalmol (2012) 0.89
KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. Hum Immunol (2008) 0.88
Human leukocyte antigen A29 subtypes associated with birdshot retinochoroidopathy. Am J Ophthalmol (2004) 0.87
Uveitis in human immunodeficiency virus-infected persons with CD4+ T-lymphocyte count over 200 cells/mL. Clin Experiment Ophthalmol (2013) 0.87
Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis. Ophthalmology (2006) 0.85
Longitudinal cohort study of patients with birdshot chorioretinopathy. IV. Visual field results at baseline. Am J Ophthalmol (2007) 0.85
An epidemic of toxoplasmosis: lessons from Coimbatore, India. Arch Ophthalmol (2010) 0.85
Rubeosis and anterior segment ischemia associated with systemic cryoglobulinemia. Am J Ophthalmol (2006) 0.84
Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with disease-associated factors and mortality. Am J Ophthalmol (2011) 0.84
Corneal pharmacokinetics of topically applied azithromycin and clarithromycin. Am J Ophthalmol (2004) 0.83
Associations of seroreactivity against crystallin proteins with disease activity and cataract in patients with uveitis. Invest Ophthalmol Vis Sci (2008) 0.81
Ocular vaccinia following exposure to a smallpox vaccinee. Am J Ophthalmol (2004) 0.81
Didanosine-associated retinal toxicity in adults infected with human immunodeficiency virus. JAMA Ophthalmol (2013) 0.81
Proportionate topographic areas of retinal zones 1, 2, and 3 for use in describing infectious retinitis. Arch Ophthalmol (2011) 0.81
Clear lens extraction with intraocular lens implantation during retinal detachment repair in patients with Acquired Immune Deficiency Syndrome (AIDS) [correction of autoimmune deficiency syndrome] and cytomegalovirus retinitis. Ophthalmology (2002) 0.81
Retinal seeding from anterior segment coccidioidomycosis after vitrectomy. Br J Ophthalmol (2007) 0.81
Longitudinal cohort study of patients with birdshot chorioretinopathy. I. Baseline clinical characteristics. Am J Ophthalmol (2006) 0.80
Late varicella-zoster virus dendriform keratitis in patients with histories of herpes zoster ophthalmicus. Am J Ophthalmol (2009) 0.80
Hemorheologic abnormalities associated with HIV infection: in vivo assessment of retinal microvascular blood flow. Invest Ophthalmol Vis Sci (2006) 0.79
Longitudinal cohort study of patients with birdshot chorioretinopathy. V. Quality of life at baseline. Am J Ophthalmol (2008) 0.78
Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with visual function. Am J Ophthalmol (2011) 0.78
Education in the ophthalmic discipline of uveitis. Am J Ophthalmol (2008) 0.78
Herpes zoster ophthalmicus in an otherwise-healthy child. J AAPOS (2005) 0.78
Contrast sensitivity among patients with birdshot chorioretinopathy. Am J Ophthalmol (2008) 0.78
Coding of glaucoma for patients with uveitis in the medicare database. J Glaucoma (2006) 0.76
Clinical features of newly diagnosed cytomegalovirus retinitis in northern Thailand. Am J Ophthalmol (2012) 0.76
An assessment of polymorphonuclear leukocyte rigidity in HIV-infected individuals after immune recovery. Invest Ophthalmol Vis Sci (2002) 0.75
Posterior intracorneal opacities in patients with HIV infection. Ocul Immunol Inflamm (2005) 0.75
The enigma of pars planitis, revisited. Am J Ophthalmol (2006) 0.75
External ophthalmoplegia in human immunodeficiency virus-infected patients receiving antiretroviral therapy. J AAPOS (2012) 0.75
Diagnostic and therapeutic challenges. Retina (2011) 0.75
Uveitis in 2008: a festschrift for G. Richard O'Connor, MD. Am J Ophthalmol (2008) 0.75
InternetAdvance: accelerated internet publication of articles and reports at ajo.com. Am J Ophthalmol (2002) 0.75
Festschrift: a tribute to the accomplishments of Bradley R Straatsma, MD, JD. Am J Ophthalmol (2003) 0.75